All In Biotech

Drug Trial Radar · NCT01575613

Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission

Reducing the Burden of Malaria by Targeting Hotspots of Transmission and Improving Malaria Control Measures in the Highlands of Western Kenya: Simultaneous Rollout of Four Malaria Control Interventions and Evaluation by Cross-sectional Surveys

Last checked: Nov 19, 2026Latest source record: Nov 27, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 17,506 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

17,506

Actual

Start

Apr 2012

Primary completion

Nov 2012

Study completion Nov 2012

Sponsor

Lead sponsor
Radboud University Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
London School of Hygiene and Tropical Medicine; Kenya Medical Research Institute; Centers for Disease Control and Prevention; International Centre of Insect Physiology and Ecology (ICIPE); Division of Malaria Control, Ministry of Health, Nairobi, Kenya
First posted
Apr 11, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 6 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

In this study, the investigators propose to determine the value of rolling out four targeted malaria control efforts in reducing overall malaria transmission. These targeted control efforts include local upscaling of IRS and ITNs in hotspots of malaria transmission. In addition, larviciding will be employed to target malaria vectors, also those that are less susceptible to IRS and ITNs as a consequence of outdoor feeding and resting. Lastly, the human infectious reservoir will be reduced in hotspots of malaria transmission by treating parasite carriers and their household members with the current first-line antimalarial drug. The impact of these targeted interventions on overall transmission intensity will be assessed in the context of currently ongoing malaria control activities in a plausibility study. Hotspots of malaria transmission are defined in an area of 100km2 and randomized to receive hotspot targeted interventions and compared with their baseline and with control clusters where the routine (untargeted) malaria control activities continue. The interventions will be evaluated based on changes in parasite prevalence measured in community surveys inside and outside hotspots of malaria transmission. Parasite prevalence will be compared before and after the intervention in intervention clusters and between intervention and control clusters. In addition to malaria surveys in the human population, an entomological evaluation will take place where the densities of mosquito larvae and adult mosquitoes are monitored longitudinally.

Conditions

  • Malaria

Interventions

  • Artemether-lumefantrine combinationDrug

    Focal screening and treatment in all households in malaria hotspots prior to the peak transmission season. Screening of a sentinel age group by rapid diagnostic tests; all parasitaemic individuals and household members of parasitaemic individuals will be treated.

  • Bacillus thuringiensisBiological

    Treatment of all waterbodies within hotspots with Bti or Bs on weekly basis

  • Long lasting insecticide treated net (LLINs)Biological

    Distribution of LLINs in all households in malaria hotspots; instruction about correct use.

  • Indoor Residual Spraying (IRS)Biological

    6-monthly IRS with deltamethrin in all households malaria hotspots.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Parasite prevalence in the evaluation zone surrounding malaria hotspotsTime frame: 3 cross-sectional surveys in up to 210 days, the timing being: at enrolment; 45-75 days post enrolment (coinciding with the peak malaria transmission season) and 150-210 days post enrolment (coinciding with the end of the malaria transmission season)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Rachuonyo District, Kenya

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.